MARKET WIRE NEWS

Fidelity Disruptors ETF: Example Why I Avoid Fund-Of-Funds

Source: SeekingAlpha

2025-06-02 09:30:00 ET

Summary

  • FDIF offers exposure to all five Fidelity Disruptive ETFs, making it suitable for investors who don't want to pick individual winners.
  • The fund has underperformed broad market benchmarks and most underlying ETFs, raising concerns about its effectiveness as a core holding.
  • FDIF only makes sense for those seeking convenience, as it doesn't deliver superior returns or risk-adjusted performance compared to broad index funds.
  • Given its lackluster performance and inconsistent payouts, I rate FDIF a Hold, with a Sell rating also worth considering.

Introduction

Now that all the ETFs held by the Fidelity Disruptors ETF ( FDIF ) have been reviewed, it was time to cover this fund-of-funds [FOF] to answer the question: “Is FDIF a good way to play the five ETFs in the Fidelity Disruptive series. Before rending my verdict, FDIF is reviewed and its performance compared to its holdings and then two broad-market ETFs. ...

Read the full article on Seeking Alpha

For further details see:

Fidelity Disruptors ETF: Example Why I Avoid Fund-Of-Funds
Fidelity Disruptive Medicine ETF

NASDAQ: FMED

FMED Trading

0.42% G/L:

$26.06 Last:

4,557 Volume:

$26.08 Open:

mwn-ir Ad 300

FMED Latest News

July 20, 2025 01:58:00 pm
(FMED) Investment Analysis and Advice
July 10, 2025 03:10:00 am
How to Take Advantage of moves in (FMED)
June 29, 2025 03:42:00 pm
Learn to Evaluate (FMED) using the Charts
April 04, 2025 08:16:00 pm
Objective long/short (FMED) Report

FMED Stock Data

$63,159,452
2,440,002
N/A
N/A
US

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App